OverviewIn this role, you will bridge Disease Biology, Clinical Development and Portfolio & Disease Strategy to translate science into portfolio-relevant priorities.
You will assess biological rationale and translational robustness for opportunities, integrating scientific and development inputs into portfolio decisions.
You'll support external asset evaluation, governance discussions and risk visibility, ensuring alignment with disease strategy while guiding evidence requirements and biomarkers considerations.
This position sits in the IMID Derma Area and partners with senior stakeholders to shape strategy and investment choices that impact patient outcomes.
ResponsabilidadesTranslate disease biology into portfolio-aligned scientific priorities and pre-candidate directions
Assess biological rationale, tractability, and translational robustness of opportunities
Consolidate scientific and early development inputs for cross-functional opportunity assessments
Contribute to scientific evaluation of external assets and partnerships
Support comparative evaluation of opportunities using established scientific and strategic criteria
Incorporate disease biology and clinical development perspectives into portfolio recommendations
Clarify evidence needs, biomarkers, and translational strategies for POC success
Highlight scientific risks associated with proposed opportunities
Provide scientific input to portfolio prioritization and asset-level decisions
Challenge mechanism validity, differentiation potential, and early development feasibility
Integrate inputs from Disease Biology and Clinical Development into portfolio recommendations




Define guardrails for external search and opportunity filtering
Ensure governance discussions reflect scientific opportunities, risks and uncertainties
Engage with cross-functional teams to align on scientific opportunities across governance forums
Requisitos principalesAdvanced degree in Life Sciences, Medicine, Pharmacy or related discipline (PhD/MD/PharmD strongly preferred)
8-10+ years in biopharmaceuticals across Disease Biology, Translational Medicine, Clinical Development, Early Development and/or Portfolio Strategy
Strong experience in drug discovery, translational science and early development with evidence-based decision-making
Experience evaluating mechanisms of action, target biology, biomarkers and development feasibility across multiple assets
Proven track record in asset strategy, portfolio reviews, governance discussions or investment decisions
Ability to integrate scientific, clinical and portfolio perspectives into strategic recommendations
Experience in matrixed cross-functional environments (Research, Clinical Development, Medical Affairs, Portfolio)
Understanding of external innovation assessment, due diligence inputs and opportunity screening
Experience presenting complex scientific concepts to senior stakeholders and governance committees
Prior experience in IMID Derma Area space
Excellent communication and stakeholder management, with ability to align diverse functions
Proficient English; other languages appreciated
Strong communication
Stakeholder management
Cross-functional collaboration
Drug discovery
Translational science
Biomarker strategy

📌 Ass. Director, Scientific Portfolio (Barcelona)
🏢 Almirall
📍 Barcelona